The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This study will test the usefulness of the medication metformin in treating people with
schizophrenia or schizoaffective disorder who are overweight and also taking antipsychotic
medications.